Lyell Immunopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.About LYEL
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.
CEOLynn Seely
CEOLynn Seely
Employees224
Employees224
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2018
Founded2018
Employees224
Employees224
LYEL Key Statistics
Market cap601.19M
Market cap601.19M
Price-Earnings ratio-2.38
Price-Earnings ratio-2.38
Dividend yield—
Dividend yield—
Average volume925.85K
Average volume925.85K
High today$2.29
High today$2.29
Low today$2.02
Low today$2.02
Open price$2.04
Open price$2.04
Volume1.18M
Volume1.18M
52 Week high$3.97
52 Week high$3.97
52 Week low$1.32
52 Week low$1.32